Lista de obras - Philip Bruggmann - Dominio Público Uruguay

"Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis

artículo científico publicado en 2014

Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.

artículo científico

Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.

artículo científico publicado en 2008

Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital.

artículo científico publicado en 2005

An integrated model of care to counter high incidence of HIV and sexually transmitted diseases in men who have sex with men - initial analysis of service utilizers in Zurich

artículo científico publicado en 2008

Birth year distribution in reported hepatitis C cases in Switzerland.

artículo científico publicado en 2014

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study

artículo científico publicado en 2017

Chronic Hepatitis C virus infection in Swiss primary care practices: low case loads-high barriers to treatment?

artículo científico publicado en 2011

Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection ⬇️

artículo científico publicado el 17 de mayo de 2013

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

article published in 2018

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

artículo científico publicado en 2014

Management of hepatitis C virus (HCV) infection in drug substitution programs

artículo científico publicado en 2011

Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.

artículo científico

Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugs.

artículo científico publicado en 2013

Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?

artículo científico publicado en 2014

Prevention, treatment and care of hepatitis C virus infection among people who inject drugs

artículo científico publicado en 2014

QTc prolongation in methadone maintenance--the role of HCV infection.

artículo científico publicado en 2013

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

artículo científico publicado en 2013

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs

artículo científico publicado en 2017

Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue

artículo científico publicado en 2014

Strategies to manage hepatitis C virus (HCV) disease burden.

artículo científico publicado en 2014

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

artículo científico publicado en 2014

Treatment as prevention: the breaking of taboos is required in the fight against hepatitis C among people who inject drugs.

artículo científico publicado en 2013

Treatment of hepatitis C - an imminent revolution

artículo científico publicado en 2014

Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study.

artículo científico publicado en 2010

Lista de obras de Philip Bruggmann

"Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis

Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.

Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.

Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital.

An integrated model of care to counter high incidence of HIV and sexually transmitted diseases in men who have sex with men - initial analysis of service utilizers in Zurich

Birth year distribution in reported hepatitis C cases in Switzerland.

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study

Chronic Hepatitis C virus infection in Swiss primary care practices: low case loads-high barriers to treatment?

Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection ⬇️

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Management of hepatitis C virus (HCV) infection in drug substitution programs

Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.

Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugs.

Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?

Prevention, treatment and care of hepatitis C virus infection among people who inject drugs

QTc prolongation in methadone maintenance--the role of HCV infection.

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs

Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue

Strategies to manage hepatitis C virus (HCV) disease burden.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Treatment as prevention: the breaking of taboos is required in the fight against hepatitis C among people who inject drugs.

Treatment of hepatitis C - an imminent revolution

Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study.